electroCore,

electroCore, Piotroski F-Score

The Piotroski F-Score of electroCore, (ECOR) as of Oct 17, 2026 is 4. In the previous year, Piotroski F-Score was 5.00 — a change of -20.00% (lower).

Piotroski F-Score

4

YoY

-20.00%

Last updated:

Piotroski F-Score of electroCore, is 2025 4 . Piotroski F-Score of electroCore, was 2024 5.00 . It decreases by -20.00% lower compared to the previous year.

The electroCore, Piotroski F-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Piotroski F-Score
Date
Piotroski F-Score
Jan 1, 2018
4.00 USD
Jan 1, 2019
4.00 USD
Jan 1, 2020
4.00 USD
Jan 1, 2021
6.00 USD
Jan 1, 2022
4.00 USD
Jan 1, 2023
4.00 USD
Jan 1, 2024
5.00 USD
Jan 1, 2025
4.00 USD
The electroCore, Piotroski F-Score history
YEARPiotroski F-ScoreYoY
4-20.00%
5+25.00%
40.00%
4-33.33%
6+50.00%
40.00%
40.00%
40.00%
4—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Piotroski F-Score of electroCore, is 4 in 2025.

On Eulerpool you can find the complete historical development of Piotroski F-Score electroCore, since 2006 – with annual values, charts, and detailed analysis.

The Piotroski F-Score rates a company from 0-9 based on profitability, leverage, liquidity, and operating efficiency. Scores of 8-9 indicate strong fundamentals.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — electroCore,

All Key Metrics — electroCore,